Amphastar Pharmaceuticals, Inc. (AMPH) vs Immatics N.V. (IMTX)
A side-by-side comparison of Amphastar Pharmaceuticals, Inc. and Immatics N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AMPH
Amphastar Pharmaceuticals, Inc.
$25.91HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
IMTX
Immatics N.V.
$7.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AMPH vs IMTX
growth of $100 · dividends reinvested · last 8yAMPH +19.4% (+2.2%/yr)IMTX -19.5% (-2.7%/yr)AMPH compounded faster over this window
AMPH IMTX
AMPH vs IMTX: by the numbers
- •AMPH is the larger company ($1.14B vs $1.01B market cap).
- •AMPH is profitable (10.76% net margin) while IMTX runs a net loss (-493.26%).
- •AMPH grew revenue faster over the past five years (13.71% vs 6.40% CAGR).
Metrics side by side
Valuation
| Metric | AMPH | IMTX |
|---|---|---|
| P/E ratio | 15.33 | N/A |
| Forward P/E | 8.72 | N/A |
| PEG ratio | 0.11 | N/A |
| P/S ratio | 1.56 | 20.72 |
| P/B ratio | 1.49 | 2.20 |
| EV / EBITDA | 8.95 | N/A |
| FCF yield | 13.38% | N/A |
Profitability
| Metric | AMPH | IMTX |
|---|---|---|
| Gross margin | 47.68% | 100.00% |
| Operating margin | 15.66% | -377.11% |
| Net margin | 10.76% | -493.26% |
| ROE | 10.23% | -52.47% |
| ROIC | 5.93% | -53.36% |
Growth (annualized)
| Metric | AMPH | IMTX |
|---|---|---|
| Revenue CAGR (5Y) | 13.71% | 6.40% |
| EPS CAGR (5Y) | 134.23% | N/A |
| FCF CAGR (5Y) | 23.90% | N/A |
| Total return CAGR (5Y) | 6.13% | -9.88% |
Frequently asked
- Which has grown faster, AMPH or IMTX?
- Over the past five years, AMPH grew revenue faster — AMPH at a 13.71% CAGR versus IMTX at 6.40%.
- Is AMPH or IMTX more profitable?
- AMPH runs the higher net margin — AMPH at 10.76% versus IMTX at -493.26%.
- How have AMPH and IMTX total returns compared?
- Over the past 5 years, AMPH delivered 6.13% and IMTX delivered -9.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Amphastar Pharmaceuticals P/E ratioAmphastar Pharmaceuticals ROEImmatics ROEAmphastar Pharmaceuticals operating marginImmatics operating marginAmphastar Pharmaceuticals revenue growthImmatics revenue growthAmphastar Pharmaceuticals free cash flowImmatics free cash flow
Amphastar Pharmaceuticals & Immatics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.